Publications by authors named "Peter E Zage"

35Publications

Characterization of G-CSF receptor expression in medulloblastoma.

Neurooncol Adv 2020 Jan-Dec;2(1):vdaa062. Epub 2020 May 27.

Department of Pediatrics, Division of Hematology-Oncology, University of California San Diego, La Jolla, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/noajnl/vdaa062DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316203PMC
May 2020

Mechanisms of Efficacy of the FGFR1-3 Inhibitor AZD4547 in Pediatric Solid Tumor Models.

Invest New Drugs 2020 Dec 20;38(6):1677-1686. Epub 2020 May 20.

Department of Pediatrics, Division of Hematology-Oncology, University of California San Diego, 3855 Health Sciences Dr., MC 0815, La Jolla, CA, 92093, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-020-00933-2DOI Listing
December 2020

The Potential Functional Roles of NME1 Histidine Kinase Activity in Neuroblastoma Pathogenesis.

Int J Mol Sci 2020 May 7;21(9). Epub 2020 May 7.

Department of Pediatrics, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA 92093, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms21093319DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247550PMC
May 2020

The multikinase inhibitor RXDX-105 is effective against neuroblastoma and .

Oncotarget 2019 Oct 29;10(59):6323-6333. Epub 2019 Oct 29.

Department of Pediatrics, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.27259DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824878PMC
October 2019

Novel Therapies for Relapsed and Refractory Neuroblastoma.

Authors:
Peter E Zage

Children (Basel) 2018 Oct 31;5(11). Epub 2018 Oct 31.

Department of Pediatrics, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA 92093, USA.

View Article

Download full-text PDF

Source
http://www.mdpi.com/2227-9067/5/11/148
Publisher Site
http://dx.doi.org/10.3390/children5110148DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262328PMC
October 2018

Overview and recent advances in the treatment of neuroblastoma.

Expert Rev Anticancer Ther 2017 Apr 15;17(4):369-386. Epub 2017 Mar 15.

b Department of Pediatrics, Division of Hematology-Oncology , University of California San Diego, La Jolla, CA and Peckham Center for Cancer and Blood Disorders, Rady Children's Hospital , San Diego , CA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2017.1285230DOI Listing
April 2017

The novel kinase inhibitor ponatinib is an effective anti-angiogenic agent against neuroblastoma.

Invest New Drugs 2016 12 1;34(6):685-692. Epub 2016 Sep 1.

Department of Pediatrics, Division of Hematology-Oncology, University of California San Diego School of Medicine, Moores Cancer Center, Room 5311, 3855 Health Sciences Drive, MC 0815, La Jolla, CA, 92093-0815, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-016-0387-yDOI Listing
December 2016

CD114: A New Member of the Neural Crest-Derived Cancer Stem Cell Marker Family.

J Cell Biochem 2017 02 16;118(2):221-231. Epub 2016 Aug 16.

Department of Pediatrics, Section of Hematology-Oncology, Children's Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcb.25656DOI Listing
February 2017

Nifurtimox Is Effective Against Neural Tumor Cells and Is Synergistic with Buthionine Sulfoximine.

Sci Rep 2016 06 10;6:27458. Epub 2016 Jun 10.

Department of Pediatrics, Section of Hematology-Oncology, Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep27458DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4901277PMC
June 2016

Binimetinib inhibits MEK and is effective against neuroblastoma tumor cells with low NF1 expression.

BMC Cancer 2016 Mar 1;16:172. Epub 2016 Mar 1.

Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-016-2199-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772351PMC
March 2016

A Polymorphism in the FGFR4 Gene Is Associated With Risk of Neuroblastoma and Altered Receptor Degradation.

J Pediatr Hematol Oncol 2016 Mar;38(2):131-8

*Section of Hematology-Oncology, Department of Pediatrics, Texas Children's Cancer Center, Baylor College of Medicine †Department of Neurobiology and Anatomy, University of Texas Medical School ‡Department of Pathology & Immunology, Baylor College of Medicine and Michael E. DeBakey VAMC, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPH.0000000000000506DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758892PMC
March 2016

Sensitivity of neuroblastoma to the novel kinase inhibitor cabozantinib is mediated by ERK inhibition.

Cancer Chemother Pharmacol 2015 Nov 25;76(5):977-87. Epub 2015 Sep 25.

Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00280-015-2871-z
Publisher Site
http://dx.doi.org/10.1007/s00280-015-2871-zDOI Listing
November 2015

CD114 Expression Mediates Melanoma Tumor Cell Growth and Treatment Resistance.

Anticancer Res 2015 Jul;35(7):3787-92

Department of Pediatrics, Section of Hematology-Oncology, Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX, U.S.A.

View Article

Download full-text PDF

Source
July 2015

The novel kinase inhibitor EMD1214063 is effective against neuroblastoma.

Invest New Drugs 2014 Oct 16;32(5):815-24. Epub 2014 May 16.

Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-014-0107-4DOI Listing
October 2014

Etoposide-loaded immunoliposomes as active targeting agents for GD2-positive malignancies.

Cancer Biol Ther 2014 Jul 22;15(7):851-61. Epub 2014 Apr 22.

Department of Nanomedicine; The Methodist Hospital Research Institute; Houston, TX USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cbt.28875DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100986PMC
July 2014

UBE4B protein couples ubiquitination and sorting machineries to enable epidermal growth factor receptor (EGFR) degradation.

J Biol Chem 2014 Jan 16;289(5):3026-39. Epub 2013 Dec 16.

From the Department of Neurobiology and Anatomy and the Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, Texas 77030.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M113.495671DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3908433PMC
January 2014

New aspects of neuroblastoma treatment: ASPHO 2011 symposium review.

Pediatr Blood Cancer 2012 Jul 29;58(7):1099-105. Epub 2012 Feb 29.

Section of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.24116DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104176PMC
July 2012

Treatment of recurrent diffuse intrinsic pontine glioma: the MD Anderson Cancer Center experience.

J Neurooncol 2012 Jan 20;106(2):391-7. Epub 2011 Aug 20.

Department of Pediatrics, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Box 87, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11060-011-0677-3
Publisher Site
http://dx.doi.org/10.1007/s11060-011-0677-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990187PMC
January 2012

Notch pathway activation induces neuroblastoma tumor cell growth arrest.

Pediatr Blood Cancer 2012 May 8;58(5):682-9. Epub 2011 Jul 8.

Division of Pediatrics, Children's Cancer Hospital, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.23202DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3264695PMC
May 2012

Gonadotropin-dependent precocious puberty: neoplastic causes and endocrine considerations.

Int J Pediatr Endocrinol 2011 6;2011:184502. Epub 2011 Mar 6.

Department of Pediatrics, The University of Texas Health Science Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2011/184502DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212801PMC
July 2011

The selective Trk inhibitor AZ623 inhibits brain-derived neurotrophic factor-mediated neuroblastoma cell proliferation and signaling and is synergistic with topotecan.

Cancer 2011 Mar 19;117(6):1321-91. Epub 2010 Oct 19.

Division of Pediatrics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.25674DOI Listing
March 2011

Chromatin remodelling at the topoisomerase II-beta promoter is associated with enhanced sensitivity to etoposide in human neuroblastoma cell lines.

Eur J Cancer 2010 Oct;46(15):2771-80

Division of Pediatrics, Children’s Cancer Hospital, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2010.05.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3025305PMC
October 2010

Signaling of ERBB receptor tyrosine kinases promotes neuroblastoma growth in vitro and in vivo.

Cancer 2010 Jul;116(13):3233-43

Department of Pediatrics Research, Children's Cancer Hospital, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.25073DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2923448PMC
July 2010

Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.

Pediatr Blood Cancer 2008 Mar;50(3):567-72

Division of Hematology/Oncology/Transplantation, Children's Memorial Hospital, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.21301DOI Listing
March 2008

Predicting tumor cell repopulation after response: mathematical modeling of cancer cell growth.

Anticancer Res 2006 Jul-Aug;26(4B):2933-6

Department of Biostatistics and Applied Mathematics, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
September 2006